[Clinical applications of the use of probiotics in pediatrics]

Guillermo Álvarez-Calatayud1, Jimena Pérez-Moreno, Mar Tolín

  • 1Sección de Gastroenterología y Nutrición Pediátrica, Hospital General Universitario Gregorio Marañón, Madrid, España. galvarezcalatayud@gmail.com

Insights

Probiotics offer a promising therapeutic option for pediatric gastrointestinal issues, though wider clinical adoption is needed. Further research into specific probiotic strains is essential for optimizing their use in children.

Area of Science:

  • Pediatric Gastroenterology
  • Microbiome Research
  • Therapeutic Innovations

Context:

  • Probiotics represent a significant advancement in pediatrics, particularly for managing gastrointestinal disorders.
  • Alterations in the intestinal microbiota are common in pediatric gastrointestinal pathologies.
  • Probiotics and prebiotics are increasingly explored for their role in childhood health.

Purpose:

  • To provide an updated review of scientific literature on probiotic use in pediatric gastroenterology.
  • To describe key applications of probiotics and prebiotics in managing childhood intestinal microbiota imbalances.
  • To outline future research directions in pediatric probiotic and prebiotic therapy.

Summary:

  • Probiotics are beneficial for various pediatric gastrointestinal conditions, including infectious diarrhea, antibiotic-associated diarrhea, and bacterial overgrowth.
  • Emerging applications include managing chronic inflammatory conditions like inflammatory bowel disease, infant colic, and constipation.
  • Evidence also supports their use in extraintestinal conditions such as allergies (atopic dermatitis), respiratory and urogenital mucosae, preterm newborn pathology, and H. pylori infection.

Impact:

  • Despite evidence, probiotics are not fully integrated into pediatric clinical practice.
  • Individual probiotic strains require extensive study to confirm efficacy and safety for specific pediatric applications.
  • Continued research is crucial for expanding the therapeutic potential of probiotics and prebiotics in pediatrics.
Abstract

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...